Update on CXL 2014

With more than 15 years of experience performing corneal crosslinking (CXL), it has become clear that CXL is an important treatment for patients with keratoconus, pellucid marginal degeneration, and post-LASIK ectasia. Since Theo Seiler, MD, ...

Full Story →